Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.973
-0.027 (-2.66%)
At close: Feb 21, 2025, 4:00 PM
0.966
-0.008 (-0.79%)
After-hours: Feb 21, 2025, 4:50 PM EST
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $80.21 million as of February 21, 2025. Its market cap has decreased by -69.36% in one year.
Market Cap
80.21M
Enterprise Value
-103.66M
1-Year Change
-69.36%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $80.21M, a decrease of -73.41%. That is a compound annual growth rate of -25.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 80.21M | 1.19% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |